GV

GV (formerly Google Ventures) is Alphabet's early-stage venture capital fund, founded in 2009. It focuses on seed through Series B investments in technology, life sciences, healthcare, and AI. GV operates independently of Alphabet's product and M&A Teams, though portfolio companies benefit from access to Google's technical infrastructure and talent network. Notable investments include Uber, Slack, Flatiron Health, and Foundation Medicine.

GV co-invested in Isomorphic Labs' Series B in May 2026, the round backed by the UK Sovereign AI Unit and alongside CapitalG and MGX. Isomorphic Labs, an Alphabet spin-out using AI for drug discovery, attracting both GV and CapitalG in the same round illustrates Alphabet's dual-track exposure to the asset: early-stage VC validation (GV) alongside growth-stage backing (CapitalG). The combination suggests Alphabet's investment structure is treating Isomorphic Labs as a genuine market-facing company rather than an internal research project.